Gara Jalqabaatti › Lymphoma Hodgkin
Qorannoo klinikaalii Lymphoma Hodgkin Ameerikaa Keessatti hirmaatuu
Qorannoo 62 Lymphoma Hodgkin f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Houston, TXQorannoo 14
- New York City, NYQorannoo 11
- Baldwin Park, CAQorannoo 9
- Boston, MAQorannoo 9
- Miami, FLQorannoo 8
- Memphis, TNQorannoo 7
- Philadelphia, PAQorannoo 6
- Atlanta, GAQorannoo 5
- Mountain View, CAQorannoo 5
- Greenburgh, NYQorannoo 5
- Durham, NCQorannoo 4
- Milwaukee, WIQorannoo 4
- Edison, NJQorannoo 4
- Queens, NYQorannoo 4
- Aurora, COQorannoo 4
- Washington, DCQorannoo 4
- Madison, WIQorannoo 4
- Los Angeles, CAQorannoo 3
- San Francisco, CAQorannoo 3
- Sacramento, CAQorannoo 3
- Baltimore, MDQorannoo 3
- Staten Island, NYQorannoo 3
- New Rochelle, NYQorannoo 3
- East Norwalk, CTQorannoo 3
- Columbus, OHQorannoo 3
- Denver, COQorannoo 3
- Orange, CAQorannoo 3
- Seattle, WAQorannoo 3
- Cincinnati, OHQorannoo 3
- Chicago, ILQorannoo 3
- Indianapolis, INQorannoo 3
- Minneapolis, MNQorannoo 3
Naannoon
- CaliforniaQorannoo 15
- ColoradoQorannoo 5
- FloridaQorannoo 12
- GeorgiaQorannoo 7
- IllinoisQorannoo 4
- IndianaQorannoo 4
- MarylandQorannoo 5
- MassachusettsQorannoo 9
- MinnesotaQorannoo 4
- New JerseyQorannoo 5
- New YorkQorannoo 15
- North CarolinaQorannoo 6
- OhioQorannoo 4
- PennsylvaniaQorannoo 7
- TennesseeQorannoo 8
- TexasQorannoo 15
- WashingtonQorannoo 4
- WisconsinQorannoo 8
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Namoota walitti qabaa jiraSadarkaa jalqabaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06398457Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 12 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06176690CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 12 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT02917083Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 0 hanga 38 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06131801The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07285044Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT03418038Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT02682667Tissue Collection for Studies of Lymph Cancer
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT01676805Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT03618550A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT05615636Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT05798897AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT06137144Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT05272384Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT07444632Cardiopulmonary Function and Cerebral Blood Flow in Hodgkin Lymphoma Survivors
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Ful-2026 · NCT06421987Phase II Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHL
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 2 hanga 21 · Saalaa hunda · Haaromfame 31-Hag-2026 · NCT07551583Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma
Namoota walitti qabaa jira
Umuriin hundi · Saalaa hunda · Haaromfame 21-Hag-2026 · NCT07514819ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT07021989CD45BE-HSPC + CART-45 Cells
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT07451054Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 12 hanga 80 · Saalaa hunda · Haaromfame 07-Hag-2026 · NCT05092451ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT06090864Personalized NK Cell Therapy in CBT
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 15 hanga 80 · Saalaa hunda · Haaromfame 30-Ado-2026 · NCT02727803A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 28-Ado-2026 · NCT07020533A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ado-2026 · NCT06150664Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ado-2026 · NCT06580002Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.